John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
M/I Homes
MHO
$3.9B
| $1.5M | ﹤0.01% |
+33,794
| New | +$1.52M |
|
|
APTX
1702
DELISTED
Aptinyx Inc. Common Stock
APTX
| $1.5M | ﹤0.01% |
432,635
+289,787
| +203% | +$1.01M |
|
1703
PUT
Edison International
EIX
$28.8B
| $1.5M | ﹤0.01% |
23,800
+14,800
| +164% | +$892K |
|
|
BZUN
1704
PUT
Baozun
BZUN
$165M
| $1.49M | ﹤0.01% |
43,400
+23,500
| +118% | +$861K |
|
1705
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $1.49M | ﹤0.01% |
+41,200
| New | +$1.41M |
|
1706
PUT
TransDigm Group
TDG
$65.9B
| $1.49M | ﹤0.01% |
+2,400
| New | +$1.32M |
|
|
ITI
1707
DELISTED
Iteris, Inc.
ITI
| $1.49M | ﹤0.01% |
262,750
+23,045
| +10% | +$110K |
|
1708
Fair Isaac
FICO
$24.6B
| $1.48M | ﹤0.01% |
2,890
-17,429
| -86% | -$8.11M |
|
|
CYBE
1709
DELISTED
Cyberoptics Corp
CYBE
| $1.48M | ﹤0.01% |
65,089
+16,981
| +35% | +$483K |
|
1710
PUT
Albemarle
ALB
$15.7B
| $1.48M | ﹤0.01% |
+10,000
| New | +$1.19M |
|
1711
PUT
AMC Global Media
AMCX
$530M
| $1.47M | ﹤0.01% |
41,200
+31,300
| +316% | +$875K |
|
1712
PUT
Newmont
NEM
$142B
| $1.47M | ﹤0.01% |
24,600
-48,000
| -66% | -$2.96M |
|
|
AGS
1713
DELISTED
PlayAGS
AGS
| $1.47M | ﹤0.01% |
204,148
+133,904
| +191% | +$610K |
|
1714
Universal Insurance Holdings
UVE
$1.2B
| $1.47M | ﹤0.01% |
97,245
+1,755
| +2% | +$24.7K |
|
1715
PUT
ConocoPhillips
COP
$158B
| $1.47M | ﹤0.01% |
36,700
-800
| -2% | -$29.5K |
|
1716
Supernus Pharmaceuticals
SUPN
$2.64B
| $1.47M | ﹤0.01% |
+58,247
| New | +$1.25M |
|
|
YARW
1717
Yarrow Bioscience
YARW
$105M
| $1.46M | ﹤0.01% |
257
+167
| +186% | +$1.05M |
|
1718
Akebia Therapeutics
AKBA
$266M
| $1.46M | ﹤0.01% |
+520,843
| New | +$1.52M |
|
1719
PUT
Coherent
COHR
$56.4B
| $1.46M | ﹤0.01% |
19,200
-28,900
| -60% | -$1.71M |
|
1720
PUT
Insulet
PODD
$9.92B
| $1.46M | ﹤0.01% |
5,700
+1,800
| +46% | +$447K |
|
1721
PUT
Lockheed Martin
LMT
$128B
| $1.46M | ﹤0.01% |
+4,100
| New | +$1.51M |
|
1722
PUT
Take-Two Interactive
TTWO
$43.6B
| $1.46M | ﹤0.01% |
7,000
-23,400
| -77% | -$4.09M |
|
|
STKL
1723
DELISTED
SunOpta
STKL
| $1.45M | ﹤0.01% |
+124,505
| New | +$1.1M |
|
1724
PUT
Akamai
AKAM
$15.2B
| $1.45M | ﹤0.01% |
+13,800
| New | +$1.44M |
|
|
KL
1725
CALL
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.45M | ﹤0.01% |
35,100
+27,500
| +362% | +$1.22M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.